Since MCP-1 is essentially involved in the pathogenesis of several inflammatory conditions, we hypothesized that it could be a major player of predictive significance and a sensitive biomarker in T2D patients with asthma that are also more likely to develop poor disease prognosis. Here, CCL2 is linked to type 2 diabetes mellitus.